Form: 10-K

Annual report [Section 13 and 15(d), not S-K Item 405]

March 5, 2026

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333- 291386) of Evommune, Inc. (the Company) of our report dated March 5, 2026, relating to the consolidated financial statements which appears in this annual Report on Form 10-K.

/s/ BDO USA, P.C.

 

New York, New York

March 5, 2026